PT747385E - Pro-farmacos de derivados de paclitaxel - Google Patents

Pro-farmacos de derivados de paclitaxel

Info

Publication number
PT747385E
PT747385E PT96109044T PT96109044T PT747385E PT 747385 E PT747385 E PT 747385E PT 96109044 T PT96109044 T PT 96109044T PT 96109044 T PT96109044 T PT 96109044T PT 747385 E PT747385 E PT 747385E
Authority
PT
Portugal
Prior art keywords
drugs
paclitaxel derivatives
pro
derivatives pro
paclitaxel
Prior art date
Application number
PT96109044T
Other languages
English (en)
Inventor
Dolatrai M Vyas
Paul M Scola
John F Kadow
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of PT747385E publication Critical patent/PT747385E/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65586Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system at least one of the hetero rings does not contain nitrogen as ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/655Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
    • C07F9/6551Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a four-membered ring
    • C07F9/65512Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a four-membered ring condensed with carbocyclic rings or carbocyclic ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PT96109044T 1995-06-06 1996-06-05 Pro-farmacos de derivados de paclitaxel PT747385E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US46924795A 1995-06-06 1995-06-06

Publications (1)

Publication Number Publication Date
PT747385E true PT747385E (pt) 2002-11-29

Family

ID=23863053

Family Applications (1)

Application Number Title Priority Date Filing Date
PT96109044T PT747385E (pt) 1995-06-06 1996-06-05 Pro-farmacos de derivados de paclitaxel

Country Status (23)

Country Link
EP (1) EP0747385B1 (pt)
JP (1) JPH08337589A (pt)
KR (1) KR100375956B1 (pt)
CN (1) CN1066151C (pt)
AR (1) AR002756A1 (pt)
AT (1) ATE222259T1 (pt)
AU (1) AU695959B2 (pt)
CA (1) CA2176191A1 (pt)
CZ (1) CZ291516B6 (pt)
DE (1) DE69622933T2 (pt)
DK (1) DK0747385T3 (pt)
ES (1) ES2181824T3 (pt)
HU (1) HUP9601524A3 (pt)
IL (1) IL118526A (pt)
MX (1) MX9601994A (pt)
NO (1) NO315233B1 (pt)
NZ (1) NZ286723A (pt)
PL (1) PL187883B1 (pt)
PT (1) PT747385E (pt)
RU (1) RU2162082C2 (pt)
SG (1) SG72692A1 (pt)
TW (1) TW354293B (pt)
ZA (1) ZA964261B (pt)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6395770B1 (en) * 1995-10-26 2002-05-28 Baker Norton Pharmaceuticals, Inc. Method and compositions for administering taxanes orally to human patients
US6495579B1 (en) 1996-12-02 2002-12-17 Angiotech Pharmaceuticals, Inc. Method for treating multiple sclerosis
US6515016B2 (en) 1996-12-02 2003-02-04 Angiotech Pharmaceuticals, Inc. Composition and methods of paclitaxel for treating psoriasis
PL337064A1 (en) * 1997-05-27 2000-07-31 Baker Norton Pharma Method of and compositions for orally administering taxanes to human beings
US6204257B1 (en) 1998-08-07 2001-03-20 Universtiy Of Kansas Water soluble prodrugs of hindered alcohols
JP2002537262A (ja) * 1999-02-18 2002-11-05 オキシジェン,インコーポレイティド 血管破壊のターゲッティングに使用するための組成物および方法
US6362172B2 (en) * 2000-01-20 2002-03-26 Bristol-Myers Squibb Company Water soluble prodrugs of azole compounds
JP2003522170A (ja) 2000-02-02 2003-07-22 フロリダ・ステイト・ユニバーシティ・リサーチ・ファウンデイション・インコーポレイテッド 抗腫瘍剤としてのc7カーボネート置換タキサン
CO5280224A1 (es) 2000-02-02 2003-05-30 Univ Florida State Res Found Taxanos sustituidos con ester en c7, utiles como agentes antitumorales y composiciones farmaceuticas que los contienen
US6750246B1 (en) 2000-02-03 2004-06-15 Bristol-Myers Squibb Company C-4 carbonate taxanes
US6916942B2 (en) 2000-02-03 2005-07-12 Bristol-Myers Squibb Company Process for the preparation of C-4 carbonate taxanes
US7063977B2 (en) 2001-08-21 2006-06-20 Bristol-Myers Squibb Company Enzymatic resolution of t-butyl taxane derivatives
KR20030049023A (ko) * 2001-12-13 2003-06-25 주식회사 코오롱 방사선 감작제용 파클리탁셀 유도체
WO2005087222A1 (en) 2004-03-05 2005-09-22 Florida State University Research Foundation, Inc. C7 lactyloxy-substituted taxanes
JP5139814B2 (ja) * 2005-02-18 2013-02-06 アブラクシス バイオサイエンス リミテッド ライアビリティー カンパニー 医療装置に結合した改善された疎水性を有した薬剤
MX2015012741A (es) 2013-03-15 2016-02-19 Concert Pharmaceuticals Inc Palbociclib deuterado.
WO2015009889A1 (en) 2013-07-18 2015-01-22 Concert Pharmaceuticals, Inc. Deuterated intedanib derivatives and their use for the treatment of proliferative disorders
JP7110094B2 (ja) * 2015-11-19 2022-08-01 バイオヘイブン・ファーマシューティカル・ホールディング・カンパニー・リミテッド 医薬化合物のアミンプロドラッグ

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX9308012A (es) * 1992-12-24 1994-08-31 Bristol Myers Squibb Co Eteres fosfonooximetilicos de derivados de taxano, solubles en agua y composiciones farmaceuticas que los incluyen.
CA2129288C (en) * 1993-08-17 2000-05-16 Jerzy Golik Phosphonooxymethyl esters of taxane derivatives

Also Published As

Publication number Publication date
HUP9601524A3 (en) 2000-03-28
MX9601994A (es) 1997-08-30
ZA964261B (en) 1997-11-27
NO962231D0 (no) 1996-05-31
ATE222259T1 (de) 2002-08-15
EP0747385B1 (en) 2002-08-14
NZ286723A (en) 1998-03-25
AU5471896A (en) 1996-12-19
CN1066151C (zh) 2001-05-23
CA2176191A1 (en) 1996-12-07
EP0747385A1 (en) 1996-12-11
HU9601524D0 (en) 1996-07-29
PL187883B1 (pl) 2004-10-29
DE69622933D1 (de) 2002-09-19
RU2162082C2 (ru) 2001-01-20
TW354293B (en) 1999-03-11
JPH08337589A (ja) 1996-12-24
CN1144805A (zh) 1997-03-12
PL314637A1 (en) 1996-12-09
KR100375956B1 (ko) 2003-04-21
DK0747385T3 (da) 2002-12-16
NO315233B1 (no) 2003-08-04
SG72692A1 (en) 2000-05-23
CZ156396A3 (en) 1996-12-11
HUP9601524A2 (en) 1997-05-28
IL118526A0 (en) 1996-10-16
DE69622933T2 (de) 2003-04-24
ES2181824T3 (es) 2003-03-01
IL118526A (en) 2001-05-20
NO962231L (no) 1996-12-09
AU695959B2 (en) 1998-08-27
CZ291516B6 (cs) 2003-03-12
AR002756A1 (es) 1998-04-29
KR970000222A (ko) 1997-01-21

Similar Documents

Publication Publication Date Title
PT833828E (pt) Derivados de rapamicina
DE69611361D1 (de) Chinazolin-derivate
DE69522717D1 (de) Chinazolinderivate
NO974103L (no) Arylsulfonylaminohydroksamsyre-derivater
DE69610698D1 (de) Chinazolin-derivate
BR9611834A (pt) Derivados de oximetóxi-3-aril-pirona
BR9605434A (pt) Derivados de purin-6-ona
ATE199150T1 (de) Diphenylmethylenpiperidin-derivate
PT747385E (pt) Pro-farmacos de derivados de paclitaxel
DE69601527D1 (de) Pyrrolylbenzimidazol-Derivate
ATA100695A (de) Prothrombin-derivate
PT856007E (pt) Derivados de ciclopeptidos
PT739892E (pt) Derivados de cromona
BR9610597A (pt) Derivados de diarilalcenilamina
DE69627830D1 (de) Pyrazol-derivate
DK0723963T3 (da) 4-Amino-benzoylguanidin-derivater
ATE177102T1 (de) Chromanderivate
DE59610106D1 (de) Fluorbenzylether-Derivate
BR9603508A (pt) Derivados de alquenil-benzoilguanidina
PT843675E (pt) Derivados de aza-antraciclinona
DE59607055D1 (de) 4-Mercapto-benzoylguanidin-Derivate
DE69620514D1 (de) 5-aminoflavon-derivate
ATA45796A (de) Lysin-prolin-derivate
BR9603733A (pt) Derivados de cloropiridilcarbonila